document.write('<link href=\"http://hosted2.ap.org/css/ComponentTypes/Headlines.css\" rel=\"Stylesheet\" type=\"text/css\" />');
document.write('');
document.write('<script type=\"text/javascript\" language=\"javascript\">');
document.write('var localScriptObj = document.createElement(\"script\");localScriptObj.setAttribute(\"type\", \"text/javascript\");localScriptObj.setAttribute(\"charset\", \"utf-8\");localScriptObj.setAttribute(\"src\", \"http://hosted2.ap.org/scripts/dynamicScript.js\");var thisheadLoc = document.getElementsByTagName(\"head\").item(0);thisheadLoc.appendChild(localScriptObj);');
document.write('</script>');
document.write('');
document.write('<script type=\"text/javascript\" language=\"javascript\">');
document.write('var localScriptObj = document.createElement(\"script\");localScriptObj.setAttribute(\"type\", \"text/javascript\");localScriptObj.setAttribute(\"charset\", \"utf-8\");localScriptObj.setAttribute(\"src\", \"http://hosted2.ap.org/scripts/cookies.js\");var thisheadLoc = document.getElementsByTagName(\"head\").item(0);thisheadLoc.appendChild(localScriptObj);');
document.write('</script>');
document.write('<link href=\"http://hosted2.ap.org/css/Hosted.css\" rel=\"Stylesheet\" type=\"text/css\" />');
document.write('<style type=\"text/css\">.apm038fd3776b0143d09f423027feb5d1e5{}');
document.write('');
document.write('');
document.write('.hdl_combo-038fd3776b0143d09f423027feb5d1e5 .ap_hdr-038fd3776b0143d09f423027feb5d1e5 {display: none; }');
document.write('');
document.write('.hdl_combo-038fd3776b0143d09f423027feb5d1e5, .hdl_combo-038fd3776b0143d09f423027feb5d1e5 .ap_hdr-038fd3776b0143d09f423027feb5d1e5 {border-style: solid;border-width: 2px;border-color: #fff; }');
document.write('');
document.write('.hdl_combo .ap_hdr-038fd3776b0143d09f423027feb5d1e5 {background:none; background-color: #fff;line-height: 24px;font-family: Arial;color: #FFFFFF;font-size: 11px;text-transform: capitalize;font-weight: bold;border-top: 0px; border-right: 0px; border-left: 0px; }');
document.write('');
document.write('.hdl_combo .ap_blk_hd-038fd3776b0143d09f423027feb5d1e5, .hdl_combo-038fd3776b0143d09f423027feb5d1e5 li a {font-family: Arial;color: #999999;font-size: 11px;font-weight: bold;text-decoration: none; }');
document.write('');
document.write('.hdl_combo .ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5, .hdl_combo-038fd3776b0143d09f423027feb5d1e5 li a {font-family: Verdana;color: #556677;font-size: 14px;text-transform: none;font-weight: bold;text-decoration: none; }');
document.write('');
document.write('.hdl_combo-038fd3776b0143d09f423027feb5d1e5 li a:hover {color: #CC3300; }');
document.write('');
document.write('.hdl_combo .ap_dt_stmp-038fd3776b0143d09f423027feb5d1e5 {font-family: Arial;color: #999999;font-size: 11px;font-style: Normal; font-weight: normal; }');
document.write('');
document.write('.hdl_combo .ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5 {font-family: Verdana;color: #999999;font-size: 11px;text-transform: none;font-style: Normal; font-weight: normal; }');
document.write('');
document.write('.hdl_combo .ap_tm_stmp-038fd3776b0143d09f423027feb5d1e5 {font-family: Arial;color: #999999;font-size: 11px;font-style: Normal; font-weight: normal; }');
document.write('');
document.write('.hdl_combo .ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5 {font-family: Verdana;color: #999999;font-size: 11px;text-transform: none;font-style: Normal; font-weight: normal; }');
document.write('');
document.write('.hdl_combo .ap_aud_icn-038fd3776b0143d09f423027feb5d1e5 {background:url(http://hosted2.ap.org/images/audioIcon.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_aud_icn-038fd3776b0143d09f423027feb5d1e5:hover {background:url(http://hosted2.ap.org/images/audioIconHover.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_vid_icn-038fd3776b0143d09f423027feb5d1e5 {background:url(http://hosted2.ap.org/images/videoIcon.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_vid_icn-038fd3776b0143d09f423027feb5d1e5:hover {background:url(http://hosted2.ap.org/images/videoIconHover.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_pic_icn-038fd3776b0143d09f423027feb5d1e5 {background:url(http://hosted2.ap.org/images/photosIcon.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_pic_icn-038fd3776b0143d09f423027feb5d1e5:hover {background:url(http://hosted2.ap.org/images/photosIconHover.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_icn_ttl-038fd3776b0143d09f423027feb5d1e5 {font-family: Arial;color: #556677;font-size: 11px;font-style: Normal; font-weight: normal;text-decoration: none;display: inline; }');
document.write('');
document.write('.hdl_combo .ap_icn_ttl-038fd3776b0143d09f423027feb5d1e5 a:hover {color: #CC3300; }');
document.write('');
document.write('.hdl_combo .ap_mlt_lnk-038fd3776b0143d09f423027feb5d1e5 {display: inline; }');
document.write('');
document.write('.hdl_combo .ap_slg_txt-038fd3776b0143d09f423027feb5d1e5 {font-family: Arial;color: #000000;font-size: 11px;font-style: Normal; font-weight: normal; }');
document.write('');
document.write('.hdl_combo-038fd3776b0143d09f423027feb5d1e5 li {border-style: solid;border-color: #fff;border-width: 2px; border-top: 0px; border-right: 0px; border-left: 0px;clear: both; padding: 5px 3px 3px 0px; margin: 0px; list-style: none; }');
document.write('');
document.write('.hdl_combo .ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5 {padding:0px 0px 0px 5px; }');
document.write('');
document.write('.hdl_combo .ap_cnt_area-038fd3776b0143d09f423027feb5d1e5 {padding-left: 0px;background-color: #FFFFFF; display:inline-block; }');
document.write('');
document.write('.hdl_combo .ap_blt_on-038fd3776b0143d09f423027feb5d1e5 li {list-style: url(http://hosted2.ap.org/images/bult.gif); }');
document.write('');
document.write('.hdl_combo .ap_li_end-038fd3776b0143d09f423027feb5d1e5 {padding-bottom: 0px; }');
document.write('');
document.write('');
document.write('');
document.write('</style></head><body>');
document.write('<script type=\"text/javascript\" language=\"javascript\">');
eval("var updateHeadlinesd00dfa02937145dcacf510ae3bdf8111 = function() { dynamicRefresh('http://hosted2.ap.org/json/KTNFAM/038fd3776b0143d09f423027feb5d1e5/uid-d00dfa02937145dcacf510ae3bdf8111', 120000, '', 'd00dfa02937145dcacf510ae3bdf8111'); }");
document.write('');
eval("setTimeout('updateHeadlinesd00dfa02937145dcacf510ae3bdf8111()', 120000);");
document.write('</script>');
document.write('<div id=\"divhdl_comboe8987ad825e7483bad199d96c51e322b\">');
document.write('');
document.write('<div class=\"hdl_combo hdl_combo-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<div class=\"ap_hdr ap_hdr-038fd3776b0143d09f423027feb5d1e5\" style=\"width:100%; display:none\">Health</div>');
document.write('');
document.write('<ul class=\"ap_cnt_area ap_cnt_area-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Skilled-Healthcare-Group-Personnel/id-p92180d8cff3241bca3bc2f3c926e77ee\">Skilled Healthcare names Rosenstock to board</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">FOOTHILL RANCH, Calif. (AP) — Nursing facility operator Skilled Healthcare Group Inc. said Monday it named Dr. Linda Rosenstock to the company\'s board of directors.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-EU-Belgium-Coma-Recovery/id-p4b5b2c634c4e4c7b99b676efad1b16c9\">Mom: Son in coma heard everything for 23 years</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">BRUSSELS (AP) — A man who emerged from what doctors thought was a vegetative state says he was fully conscious for 23 years but could not respond because he was paralyzed, his mother said Monday.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_img_lnk\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Senate-Leaders/id-p48976760ba9e429ea0ebd0fc56671d38\">');
document.write('');
document.write('<img src=\"http://hosted2.ap.org/CBImages/?media=photo&amp;contentId=71e5f7340d1d44a894274ad84e5c245e&amp;fmt=jpg&amp;Role=Thumbnail&amp;reldt=2009-11-22T02:33:14GMT&amp;authToken=eNoFwrsNwCAMBcCJjPx5xlAwDAJHokuZguGju5vfqGYdlV1DmNlZ%2ba4zQtKfMBBv2QTMRh0ahLkb0pfC8553tCK9CFDEfgJ9E4g%3d\" alt=\"Click for Full Story\" width=\"128\" height=\"89\" />');
document.write('');
document.write('</a>');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Senate-Leaders/id-p48976760ba9e429ea0ebd0fc56671d38\">For Reid, Dodd, clout on big issues cuts both ways</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">WASHINGTON (AP) — Two Senate leaders trying to steer a pair of President Barack Obama\'s high-stakes initiatives through Congress are being dogged by re-election worries, and it\'s not clear whether their legislative prominence will help or hurt them.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_img_lnk\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-FBN-Battered-Redskins/id-p808a9595cb294403bee25df59c631661\">');
document.write('');
document.write('<img src=\"http://hosted2.ap.org/CBImages/?media=photo&amp;contentId=f6607e4d79344212bb0d0dbf38598648&amp;fmt=jpg&amp;Role=Thumbnail&amp;reldt=2009-11-22T23:23:56GMT&amp;authToken=eNoFwrsNwCAMBcCJjGz88KdgGQJIdClTMHx0d9fXTTVh3KoLM3sT3Of0bca%2bMMlTQahSaQyexHNsjZZhiHveHkWyCFBEfwLaE2c%3d\" alt=\"Click for Full Story\" width=\"128\" height=\"114\" />');
document.write('');
document.write('</a>');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-FBN-Battered-Redskins/id-p808a9595cb294403bee25df59c631661\">Redskins\' RB Betts, G Rinehart out for the season</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">ASHBURN, Va. (AP) — Running back Ladell Betts and guard Chad Rinehart are done for the season for the battered Washington Redskins.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Pharmasset-Hepatitis-C/id-pdead1534c4114c5e86bdb29d63606b75\">Pharmasset: hepatitis C drug trial will continue</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">NEW YORK (AP) — Pharmasset Inc. said Monday that it will continue enrolling patients in a clinical trial of RG7128, a drug that is designed to treat the liver disease hepatitis C.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-GlaxoSmithKline-Prostate-Drug/id-p916206554c844005b98c44c44e668cdc\">GlaxoSmithKline pulls application for new drug use</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">TRENTON, N.J. (AP) — British drugmaker GlaxoSmithKline PLC said Monday it is temporarily withdrawing its application for U.S. approval of a drug to prevent prostate cancer.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-WellPoint-Mover/id-p456144416bb940ee91df04007771f8d6\">Cigna, WellPoint upgraded on costs, reform details</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">NEW YORK (AP) — An analyst for JPMorgan upgraded shares of WellPoint Inc. and Cigna Corp. Monday, saying the stocks should trade higher as the details of a federal health care reform bill come into focus.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Medtronic-Earnings-Preview/id-p05af3bf3294d456dac03a5dbdfbbcf98\">Earnings Preview: Medtronic</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">WASHINGTON (AP) — Medtronic, the world\'s largest medical device maker, reports earnings for the second fiscal quarter of 2010 on Tuesday. The following is a summary of key developments and analyst opinion for the last period.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Rigel-Mover/id-pbc54a6f5a5894562a71eee36feff390e\">Rigel shares rise on RBC analyst upgrade</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">NEW YORK (AP) — Rigel Pharmaceuticals Inc. rose after an RBC Capital Markets analyst recommended buying shares of the drug developer based on his expectations the company will announce news of a partnership for a key drug candidate.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_v_img_lnk\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-HKN-Blue-Jackets-Moves/id-p456f4a30ed6b408db4a213e489267b34\">');
document.write('');
document.write('<img src=\"http://hosted2.ap.org/CBImages/?media=photo&amp;contentId=7b084eb030f947e091a1c34471de1909&amp;fmt=jpg&amp;Role=Thumbnail&amp;reldt=2009-11-20T03:17:57GMT&amp;authToken=eNoFwrENwCAMBMCJjP6xwbhgmECIRJcyBcNHd2d9vaqGVZTsBFBzKWfu7gPN1oAonhDzBQlelKlmznsxEGe%2fvSVGolmi%2fgIUE1c%3d\" alt=\"Click for Full Story\" width=\"112\" height=\"128\" />');
document.write('');
document.write('</a>');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-HKN-Blue-Jackets-Moves/id-p456f4a30ed6b408db4a213e489267b34\">Blue Jackets F Dorsett on IR after Neal boarding</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">COLUMBUS, Ohio (AP) — The Columbus Blue Jackets have placed forward Derek Dorsett on injured reserve retroactive to Thursday.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Bristol-Myers-Asterand/id-p8247a284937b48f187b839c7015ad07b\">Bristol-Myers extends partnership with Asterand</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">NEW YORK (AP) — Drugmaker Bristol-Myers Squibb Co. and Asterand PLC are extending a research collaboration for up to three years, Asterand said Monday.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Pfizer-Cattle-Vaccines/id-p39fcce662ccc4e1493173fb93a83e2c8\">Pfizer, Immunovaccine in animal vaccine deal</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">NEW YORK (AP) — Immunovaccine Inc. said Monday that Pfizer Inc., the world\'s largest drugmaker, is licensing its technology for use in vaccines for cattle.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Raptor-Pharmaceutical-Study/id-p31b61e253d2043cb87085423beccb6d2\">Raptor\'s genetic disorder drug meets study goals</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">NOVATO, Calif. (AP) — Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Health-Care-Briefing/id-pdac815bfefe648b4b5d27a2d31a29cf1\">Health care issues: What are GOP\'s reform ideas?</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">A look at key issues in the health care debate:</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li class=\"ap_li_end ap_li_end-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-038fd3776b0143d09f423027feb5d1e5\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-038fd3776b0143d09f423027feb5d1e5\" href=\"http://hosted2.ap.org/KTNFAM/038fd3776b0143d09f423027feb5d1e5/Article_2009-11-23-US-Merck-Vioxx-Medicaid-Lawsuit/id-p887adbe33de643ad8d2d8d78a6121d4b\">Merck claims win in Texas lawsuit over Vioxx</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-038fd3776b0143d09f423027feb5d1e5\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-038fd3776b0143d09f423027feb5d1e5\">WHITEHOUSE STATION, N.J. (AP) — Merck &amp; Co. said Monday a district court judge in Texas dismissed all claims in a state Medicaid lawsuit over the painkiller Vioxx.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('</ul>');
document.write('');
document.write('</div>');
document.write('');
document.write('</div>');
document.write('</body></html>');